Sign In
Last checked at 
23 Nov 2010 09:46
ο»Ώ
Β
TR-1: Notifications of Major Interests in Shares |
Β
Β 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Β Proteome Sciences plc. | ||
Β 2. Reason for notification (yes/no) | |||
Β An acquisition or disposal of voting rights | Yes | ||
Β An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | ||
Β An event changing the breakdown of voting rights | No | ||
Β Other (please specify):______________ | No | ||
Β 3. Full name of person(s) subject to notification obligation: | Sanofi-Aventis Deutschland GmbH | ||
Β 4. Full name of shareholder(s) (if different from 3): | |||
Β 5. Date of transaction (and date on which the threshold is crossed or reached if different): | 22 November 2010 | ||
Β 6. Date on which issuer notified: | 23 November 2010 | ||
Β 7. Threshold(s) that is/are crossed or reached: | 3 % | ||
Β
8: Notified Details | |||||||
A: Voting rights attached to shares Β | |||||||
Class/type of shares If possible use ISIN code | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
Number of shares | Number of voting rights | Number of shares | Number of voting rights | Percentage of voting rights | |||
Β Direct | Β Indirect | Β Direct | Β Indirect | ||||
GB0003104196 7,465,510 7,465,410 5,712,182 5,712,182 - 2.97 % - Β | |||||||
Β
B: Financial Instruments Β | ||||
Resulting situation after the triggering transaction Β | ||||
Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
NA | NA | NA Β | NA | NA |
Β
Total (A+B) Β | |
Number of voting rights | Percentage of voting rights |
5,712,182 | 2.97 % |
Β
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
Β
Proxy Voting: Β | |
10. Name of proxy holder: Β | |
11. Number of voting rights proxy holder will cease to hold: Β | |
12. Date on which proxy holder will cease to hold voting rights: Β | |
Β
13. Additional information: Β | |
14 Contact name: Β | Juergen Blieke or Reiner May |
15. Contact telephone name: Β | 0049 69 305 4703 or 0049 69 305 80202 |
Β
Follow the stocks
